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Substantial recent evidence shows a reduction in disability among the el-
derly in the United States. Manton and Gu (2001), for example, documenta
25 percent decline in disability among the elderly population between 1982
and 1999—a reduction of over 1 percent per year. Cutler (2001) shows sim-
ilar measures of disability decline in a variety of diﬀerent surveys. The con-
sensus among researchers has moved toward the conclusion that the el-
derly are getting healthier, even as they are living longer (Freedman,
Martin, and Schoeni 2002).
The major issue raised by these ﬁndings is why disability has declined.
There is, of course, a scholarly interest in knowing why disability has fallen.
But there are public policy reasons to care as well. Understanding disabil-
ity trends is essential in making forecasts about the medical needs of the
elderly population. The disabled spend seven times what the nondisabled
do on medical care. Reductions in disability, if they continue, could thus
have large eﬀects on the medical burden of an aging society (Pardes et al.
1999). Feedback the other way is possible as well. To the extent that lower
disability is driven by increased medical spending, changes in the medical
system could inﬂuence the future health of the elderly population. Reduc-
tions in Medicare payments that reduce the growth of intensive procedure
use, for example, might adversely aﬀect the health of the aged population.
Very little is known about what factors have inﬂuenced disability trends,
although there are many possibilities. Medical advance is clearly one fac-
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to, often with the goal of reducing disability (in addition to extending life).
For the purposes of this paper, I divide medical advances into major pro-
cedures such as surgery for hip problems or heart disease, and less inten-
sive forms of therapy such as prescription medications. This is largely for
data reasons; the data that I use have information on intensive procedures
but not medication usage.
Beyond medical advance, some have attributed reduced disability to an
increasingly educated elderly population (Freedman and Martin 2002),
environmental changes such as fewer buildings with only stairs (Institute
of Medicine 1997), less strenuous work when younger (Case and Deaton,
chap. 6 in this volume), and increased use of technological aids to over-
come potential impairment (Manton, Corder, and Stallard 1993).
In this paper, I present preliminary evidence on the role of one of these
factors in explaining reductions in disability: increased medical procedure
use in response to acute episodes of disease. Procedures consist largely of
major surgical operations—open-heart surgery for people with cardiovas-
cular disease and hip replacements for people with fractures or severe
arthritis, for example. Use of these procedures has diﬀused widely, in many
cases doubling or tripling over a decade, suggesting they could play a large
role in improved health.
I document two facts about procedure receipt and disability change.
First, I show that most of the reduction in disability is not from people hav-
ing fewer disabling conditions. The share of people with a stroke, fracture,
or other serious condition has increased over time. Rather, reduced dis-
ability is because fewer people who have these conditions become disabled.
Since intensive medical care is most important after a person has an acute
event, this suggests the potential role of increased utilization of medical
services in reducing disability.
Examining speciﬁc technologies shows that receipt of intensive proce-
dures is associated with some reduction in disability, but not an enormous
amount. People with musculoskeletal problems and circulatory disease are
much more likely to get surgery now than in the past, and disability for
people with these conditions has fallen. But this is not a large share of the
total decline. Other medical and nonmedical interventions are more im-
portant in aggregate. I speculate about what other factors might be rele-
vant, but I do not provide conclusive evidence.
This paper is structured as follows. The ﬁrst section explains the measure
of disability and presents trends in disability over time. The second section
divides declining disability into reduced incidence of major conditions and
reduced disability for people who experience those conditions. The third
section examines the role of medical technology in explaining why serious
diseases are not as disabling as they used to be. The last section concludes.
162 David M. Cutler5.1 Trends in Disability
Disability has both a medical and a social component.1 In the broadest
deﬁnition, a person is disabled if he or she cannot perform the activities
usually associated with a person of that age and position in life. The ex-
pectation about what one can do clearly involves a number of diﬀerent fac-
tors. A twenty-ﬁve-year-old who cannot lift a twenty-pound box would
probably be classiﬁed as disabled; a seventy-year-old with the same inabil-
ity, in contrast, would not.
The deﬁnition of physical needs then becomes important. What is a per-
son supposed to be able to do? In practice, most researchers focus on basic
activities associated with independent living: people are classed as disabled
if they cannot perform the necessary activities needed to live on their own.
These necessary activities are of two types: physical activities of daily liv-
ing (ADLs) and social or cultural instrumental activities of daily living
(IADLs). Activities categorized as ADLs include eating, getting into and
out of bed, getting around inside, dressing, bathing, and using the toilet.
Activities categorized as IADLs consist of shopping, doing laundry, doing
light housework, demonstrating outdoor mobility, managing medications,
managing money, getting to places out of walking distance, and preparing
meals.
The deﬁnition of disability here is very strict. Disability is the very low
end of the spectrum of independent living. A person who cannot climb a
ﬂight of stairs but has no diﬃculty getting places without stairs, for ex-
ample, would not be disabled. In analyzing medical interventions, this dis-
tinction is important. Many medical interventions are designed to improve
health through better higher-end functioning. The impact of these inter-
ventions may be missed with such a measure of disability. Still, the major-
ity of research in the area examines the severe disability measure, so it is a
useful starting point.
The bulk of research on disability uses data from the National Long-
Term Care Survey (NLTCS).2 The NLTCS began in 1982 with a sample of
the community-dwelling population. It was conducted again in 1984, 1989,
1994, and 1999. In each case, people in one wave are followed in subse-
quent waves, and a new sample is drawn to keep the survey nationally rep-
resentative. The nearly twenty years of comparable data make the NLTCS
unique in health surveys.
The NLTCS has been linked to Medicare claims records. This is impor-
tant because claims records are the most reliable source of information on
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1. See Pope and Tarlov (1991) and Verbrugge and Jett (1994) for discussion.
2. Information on the NLTCS can be found on the Duke University web site, www.cds.duke
.edu.intensive medical care receipt. These claims records ﬁgure prominently in
the analysis reported here. Medicare covers hospital, physician, and labo-
ratory services. Prescription drugs are not paid for by Medicare; hence,
there is no record of them. Nor does the NLTCS ask about prescription
medications. Thus, I cannot examine the role of pharmaceutical innova-
tion.
Reliable hospital data are available from 1982 on. Physician data are gen-
erally not reliable until the early 1990s. To measure disability trends over
the longest possible time period, I use data from 1989 and 1999, restrict-
ing myself to the hospital records.3 In practice, the most reliable informa-
tion on hospital records is the major procedures that were performed.
Surgical admissions are reimbursed at a higher rate than are medical
admissions. Thus, hospitals take particular care in recording any surgical
procedures that were performed. The procedures that I examine are all
surgical.
Figure 5.1 shows basic information on trends in disability in 1984 and
every ﬁve years thereafter (see Manton and Gu 2001). The data are age ad-
justed to the 1999 population; thus, the increasingly aged population does
not mechanically lead to increased disability. In 1984, 26 percent of the eld-
erly population was disabled. That declined steadily in the subsequent ﬁf-
teen years. By 1999, less than 20 percent of the population was disabled.
The overall decline in disability is 25 percent, or 1.8 percent per year. It is
this major decline in disability that I seek to explain.
5.2 Disabling Conditions and the Extent of Disability
One way to begin the understanding of disability decline is to decompose
disability changes into the incidence of diﬀerent conditions and the extent
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3. Analysis that I have done from the 1994 and 1999 surveys using physician data as well
are generally similar.
Fig. 5.1 Disability among the elderly
Source: Manton and Gu (2001).to which those conditions produce disability. Denote medical conditions
by j   1, . . . , J. Assuming that each person has only one condition, the
probability that a person is disabled in any year is given by
(1) Pr(Disability)  ∑
j
Pr(Cj)   Pr(DCj),
where Cj is an indicator for whether a person has condition j and D indi-
cates whether the person is disabled.
To operationalize this disaggregation, we need to deﬁne a set of condi-
tions. The choices here are limited by the nature of the data. Whether the
person is disabled can be determined from surveys conducted in 1989 and
1999. The only information on the incidence of disability conditions, how-
ever, comes from claims records. We thus need to ﬁnd conditions that will
be reliably coded in claims data.
In determining whether a person had a condition, we need to decide on
a time period for measurement. The medical record data permit a measure
of disease incidence over many years. Conditions that occurred many years
in the past are unlikely to be a cause of current disability, however. To bal-
ance these concerns, I choose a time interval of two years before the survey
date.
After some exploration, I settled on the thirty-three conditions listed in
table 5.1.4 The conditions are divided by major diagnostic category. The
major categories with the most entries include musculoskeletal disorders
(for example, hip fractures and arthritis); respiratory disease (chronic ob-
structive pulmonary disease and similar diseases); circulatory disorders
(stroke and heart disease); cancer (colorectal, lung, breast, and prostate);
mental disorders (especially depression); nervous system disorders (de-
mentia, Parkinson’s); and endocrine disorders (especially diabetes). There
are thirty-one speciﬁc diseases. The last row is the composite of other con-
ditions. Some people who are disabled have no hospital admissions be-
forehand; these are included in the penultimate “no condition” row.
The last column of table 5.1 shows the share of people with that condi-
tion who were disabled in the individual survey. Admissions for dementia
and other brain diseases have the highest disability rate. Three-quarters of
people with such an admission are disabled. Other conditions with very
high disability rates are hip and pelvic fractures (74 percent), paralysis and
Parkinson’s disease (73 percent), and acute renal failure (63 percent). At
the bottom end, most cancers have only a 20 percent disability rate, and
genitourinary diseases are similarly nondisabling. Somewhat surprisingly,
15 percent of people never admitted to a hospital in a two-year period are
disabled at the end of that period.
These relative disability rates are important in considering equation (1).
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4. McClellan and Yan (2000) use a similar list.Table 5.1 List of conditions and disability probability
Disability 
Condition ICD-9-CM codes probability (%)
Musculoskeletal
Arthritis and arthropathy 274.∗, 390.∗, 710.∗–716.∗ 38
Back/Neck pain 720.∗–724.∗, 839.0–839.5, 846.∗, 847.∗ 31
Hip and pelvic fracture 808.∗, 820.∗ 74
Musculoskeletal disorders 717.∗–739.∗ (~#29), 800.∗–999.∗ (~#29, #30) 34
Digestive
Gastrointestinal disease 530.∗–579.∗, 789.0, 787.0, 787.7 30
Respiratory
Chronic obstructive pulmonary  466.∗, 490.∗–496.∗, 518.12 36
diseases and related diseases
Respiratory failure and  518.∗, 799.1 46
insuﬃciency
Respiratory diseases 460.∗–519.∗ (~#22, #23), 786.0, 786.1, 786.52,  37
793.1
Circulatory
Stroke 362.34, 430.∗, 431.∗, 432.9, 433.∗–436.∗ 50
Hypertension 401.∗–405.∗ (~#16), 437.0, 437.9 32
Ischemic heart disease 410.∗–414.∗ (~414.11, 414.19), 429.5–429.7 30
Heart failure and arrhythmia 425.∗, 427.1, 427.3–427.5, 428.∗, 429.1, 429.3 46
Peripheral vascular disease 440.∗, 442.∗, 443.∗ (~443.2), 444.∗, 446.∗, 41
447.∗ (~447.6), 451.∗, 453.1
Circulatory diseases 391.∗–459.∗ (~#13, #14, #16, #17, #18, #19,  32
#20), 786.5, V717.∗
Infectious disease
Infectious diseases 001.∗–139.∗, 320.∗–323.∗, V09.∗ 40
Cancer
Colorectal and lung cancer 153.∗, 154.∗, 162.∗ 30
Breast and prostate cancer 174.∗–175.∗, 185.∗ 20
Other cancers 140.∗–239.∗ (~#2, #3), 611.72, V10 23
Genitourinary diseases
Chronic renal failure 403.01, 403.11, 403.91, 404.02, 404.12, 404.92,  54
585.∗–586.∗, V45.1, V56.∗
Acute renal failure and 
insuﬃciency 584.∗, 587.∗, 588.∗ 63
Genitourinary diseases 580.∗–629.∗ (~#4, #16, #25, #26), 788.∗ 28
(~788.3, 788.4), 793.8, V44.5–V44.6, 
V55.5–V55.6
Mental disorders
Depression 296.∗ (~296.9), 298.0, 300.4, 311.∗ 44
Other mental disorders 290.∗–319.∗ (~#10, #11), 797.∗ 49
Nervous system and sensory
Dementia and organic brain 
diseases 290.∗, 294.∗, 310.∗, 330.∗, 331.∗ 78
Paralysis, Parkinson’s, etc. 332.∗, 340.∗–344.∗, 438.∗ 73
Glaucoma and cataract 365.∗–366.∗, 743.2–743.3 28Equation (1) is only correct if each person has only one condition. In prac-
tice, some people have more than one condition. There is a generalization
of equation (1) that allows for multiple conditions.5 The cross-correlations
between conditions are generally fairly low, however, meaning that there
are a lot of cross-conditions with few people in them.
To avoid dealing with many comorbidities with small numbers, I assign
each person to only one condition—the one with the highest disability
probability. For example, a person admitted with respiratory failure and
insuﬃciency (46 percent disability rate) and diabetes (40 percent disability
rate) is classiﬁed as having respiratory failure and insuﬃciency.
With this assignment system, table 5.2 shows how these conditions con-
tribute to lower disability. The ﬁrst two columns show the probability of
having each condition and the disability associated with that condition in
1989; the next two columns report the same ﬁgures for 1999. The ﬁfth and
sixth columns show disability through each of these paths (the product of
the two columns for that year), and the seventh column shows the change
in disability from that path.
Overall, disability rates fell by 5.7 percentage points, as shown in the last
row of the table.6 The biggest decline in disability comes from musculo-
skeletal disorders. Reduced disability through that channel accounts forone-
quarter of the total decline. Digestive and respiratory disorders together
account for that amount as well. There is also a large decline in disability
for people with no hospitalizations. This path accounts for 40 percent of
the total reduction in disability.
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Table 5.1 (continued)
Disability 
Condition ICD-9-CM codes probability (%)
Blood
Anemia 280.∗–285.∗ 43
Other blood diseases 285.∗–289.∗ 37
Endocrine, nutritional, metabolic
Diabetes 250.∗, 251.3 40
Thyroid disorders 240.∗–259.∗ (~#5) 30
Other metabolic and immunity 
disorders 270.∗–273.∗, 275.∗–279.∗ 28
Other
No condition 15
Composite category All other codes 29
5. Multiple conditions can conceptually be treated as conditions of their own. In practice,
following this strategy does not change the conclusions.
6. These numbers diﬀer from those in ﬁgure 5.1 because of diﬀerent years of age adjust-
ment.Table 5.2 Medical conditions associated with reduced disability (%)
1989 1999 Disability probability
Condition Pr[C] Pr[DC] Pr[C] Pr[DC] 1989 1999 Change Total
Musculoskeletal
1 Arthritis and arthropathy 2.6 37.4 3.6 25.0 1.0 0.9 –0.1 –1.3
2 Back/Neck pain 1.2 20.3 1.8 15.8 0.3 0.3 0.0
3 Hip and pelvic fracture 1.8 77.1 1.4 67.8 1.4 0.9 –0.5
4 Musculoskeletal disorders 8.6 27.6 9.0 17.9 2.4 1.6 –0.8
Digestive
5 Gastrointestinal disease 4.9 21.0 3.1 12.2 1.0 0.4 –0.6 –0.6
Respiratory
6 Chronic obstructive 
pulmonary diseases and 
related diseases 1.9 31.6 2.1 17.2 0.6 0.4 –0.2 –0.6
7R e spiratory failure and 
insuﬃciency 0.6 55.3 0.9 39.1 0.3 0.3 0.0
8R e spiratory diseases 3.4 32.5 3.6 21.2 1.1 0.8 –0.3
Circulatory system
9 Stroke 3.8 51.2 4.7 39.1 1.9 1.8 –0.1 –0.3
10 Hypertension 1.5 22.0 2.5 16.0 0.3 0.4 0.1
11 Ischemic heart disease 1.8 25.7 1.4 17.1 0.5 0.2 –0.2
12 Heart failure and 
arrhythmia 3.6 43.3 5.3 37.0 1.6 2.0 0.4
13 Peripheral vascular disease 1.3 35.7 1.5 24.2 0.5 0.4 –0.1
14 Circulatory diseases 3.3 22.5 2.8 12.3 0.8 0.3 –0.4
Infectious disease
15 Infectious diseases 1.4 39.8 1.4 25.9 0.5 0.4 –0.2 –0.2
Cancer
16 Colorectal and lung 
cancer 0.3 23.4 0.1 31.0 0.1 0.0 0.0 –0.1
17 Breast and prostate cancer 0.2 13.5 0.2 14.9 0.0 0.0 0.0
18 Other cancers 1.1 12.8 0.6 7.5 0.1 0.0 –0.1
Genitourinary diseases
19 Chronic renal failure 0.3 59.0 0.5 52.5 0.2 0.3 0.1 –0.1
20 Acute renal failure and 
insuﬃciency 0.1 74.5 0.2 54.8 0.1 0.1 0.0
21 Genitourinary diseases 2.2 17.2 1.1 14.6 0.4 0.2 –0.2
Mental disorders
22 Depression 0.3 23.7 0.5 33.0 0.1 0.2 0.1 0.0
23 Other mental disorders 1.4 41.5 1.3 36.9 0.6 0.5 –0.1
Nervous system and sense organs
24 Dementia and organic 
brain diseases 1.1 82.2 1.5 77.5 0.9 1.2 0.3 0.1
25 Paralysis, Parkinson’s, etc. 1.0 70.0 1.1 67.0 0.7 0.7 0.0
26 Glaucoma and cataract 1.4 25.0 0.7 13.8 0.3 0.1 –0.2Table 5.2 suggests a mixed conclusion about the potential importance of
intensive interventions in explaining the decline in disability. Musculo-
skeletal disorders are certainly responsive to medical intervention; hip re-
placements and back or neck procedures are among the most rapidly ex-
panding medical procedures. On the other hand, there is little surgical
therapy for infectious disease and respiratory disease, each of which have
had reductions in disability. And clearly, no surgical therapy was performed
on people without a hospital record. Increased use of intensive therapies
can thus explain some, but certainly not all, of the reduction in disability.
5.2.1 Incidence of Conditions and Disability Rate
More information on the nature of reduced disability comes from de-
composing disability declines into changes in the probability of having a
disease and the extent to which diseases lead to disability. Following equa-
tion (1), we can approximate7the change in disability between two time pe-
riods as
(2)  Pr(Disability)  ∑
j
 Pr(Cj)   Pr(DCj)  ∑
j
Pr(Cj)    Pr(DCj).
The ﬁrst term on the right-hand side is the eﬀect of changes in event
probabilities on disability; the second is the eﬀect of changes in the condi-
tional disability rate. Performing this decomposition will tell us whether
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Table 5.2 (continued)
1989 1999 Disability probability
Condition Pr[C] Pr[DC] Pr[C] Pr[DC] 1989 1999 Change Total
Blood
27 Anemia 1.4 37.4 2.1 30.7 0.5 0.6 0.1 0.1
28 Other blood diseases 0.4 11.5 0.4 14.3 0.0 0.1 0.0
Endocrine, nutritional, metabolic
29 Diabetes 2.2 31.3 3.9 24.9 0.7 1.0 0.3 0.2
30 Thyroid disorders 0.3 14.6 0.5 4.8 0.0 0.0 0.0
31 Other metabolic and 
immunity disorders 0.4 30.8 0.3 8.2 0.1 0.0 –0.1
Other
32 No condition 37.1 17.2 31.7 12.8 6.4 4.1 –2.3 –2.8
33 Composite category 7.3 22.0 8.3 13.2 1.6 1.1 –0.5
Total 26.9 21.2 –5.7
Notes:These are weighted (using CDS screener cross-sectional weights) observed rates in 1989 and 1999.
Weights are age and sex standardized to 1999.
7. The equation is approximate because there is an omitted covariance term between
changes in incidence and conditional disability rates.disability is falling because fewer people are at risk for disability or because
the same events are less disabling over time. Intensive medical care will be
more likely to reduce disability among people with a disease than to pre-
vent the disease in the ﬁrst place.
Table 5.3 shows the decomposition. In total, more people have condi-
tions in 1999 than did in 1989. As the penultimate row shows, 5.4 percent
fewer people had no condition in 1999 than did in 1989. As a result of this
increase in the probability of having disabling conditions, changes in the
event probability rate alone would suggest an increase in disability over
time. The amount, shown in the last row of the table, is 1.8 percent.
The overwhelming reason why disability has declined is because the con-
ditions that people have are less disabling than they used to be. This ﬁnd-
ing is true for the vast bulk of conditions. For the typical condition, the dis-
ability rate for people who have the condition was about 10 percent lower
in 1999 than it was a decade earlier.
The ﬁndings that more people have each condition and that fewer people
with each condition are disabled suggests a possible selection story—more
people survive severe episodes now than in the past and thus report hospi-
talizations for them. That would not be a particular problem for the anal-
ysis; we want to capture increasing disability resulting from more “mar-
ginal survivors.”
Two other possibilities are more problematic, however. One possibility
is that diagnosis of marginal cases has increased, and the new people with
each condition are not as seriously aﬀected as those who were diagnosed
previously. This would lead to a mechanical ﬁnding that the incidence of
disabling conditions was rising but that disability for people with those
conditions was falling. Since the conditions chosen are generally severe
and relatively clear to diagnose, however, this is somewhat less likely. A hip
fracture is not a very ambiguous diagnosis, for example.
Alternatively, it may be that people have these diagnoses because they
are obtaining particular therapies that were not previously provided. For
example, a person with severe arthritis who now receives a hip replacement
will be admitted to a hospital for the operation and receive an arthritis
drug, where previously there was no admission for that condition. In these
data, we have no way to test for this. It is thus necessary to interpret the de-
composition with some caution.
5.3 Intensive Medical Care and Disability
The question I address is how much of the reduction in disability can be
explained by increased use of intensive procedures. To assemble a list of
important interventions, I looked at the procedures that are common for
these diseases. Table 5.4 shows the resulting list, and table 5.5 shows a con-
cordance between diseases and procedures. Relevant procedures diﬀer
170 David M. CutlerTable 5.3 Decomposition of changes in disability
Eﬀect of change in:
Probability of condition Conditional disability rate
Condition dPr[C] Pr[DC] Total d(Pr[DC]) Pr[C] Total
Musculoskeletal
1 Arthritis and arthropathy 1.0 37.4 0.4 –12.4 2.6 –0.3
2 Back/Neck pain 0.5 20.3 0.1 –4.5 1.2 –0.1
3 Hip and pelvic fracture –0.4 77.1 –0.3 –9.3 1.8 –0.2
4 Musculoskeletal disorders 0.4 27.6 0.1 –9.8 8.6 –0.8
Digestive
5 Gastrointestinal disease –1.8 21.0 –0.4 –8.8 4.9 –0.4
Respiratory
6 Chronic obstructive pulmonary 
diseases and related diseases 0.2 31.6 0.1 –14.4 1.9 –0.3
7R e spiratory failure and insuﬃciency 0.3 55.3 0.1 –16.3 0.6 –0.1
8R e spiratory diseases 0.2 32.5 0.1 –11.3 3.4 –0.4
Circulatory system
9 Stroke 0.9 51.2 0.5 –12.1 3.8 –0.5
10 Hypertension 1.0 22.0 0.2 –6.0 1.5 –0.1
11 Ischemic heart disease –0.4 25.7 –0.1 –8.6 1.8 –0.2
12 Heart failure and arrhythmia 1.7 43.3 0.7 –6.3 3.6 –0.2
13 Peripheral vascular disease 0.2 35.7 0.1 –11.5 1.3 –0.1
14 Circulatory diseases –0.6 22.5 –0.1 –10.2 3.3 –0.3
Infectious disease
15 Infectious diseases 0.0 39.8 0.0 –13.9 1.4 –0.2
Cancer
16 Colorectal and lung cancer –0.2 23.4 0.0 7.5 0.3 0.0
17 Breast and prostate cancer 0.0 13.5 0.0 1.5 0.2 0.0
18 Other cancers –0.5 12.8 –0.1 –5.2 1.1 –0.1
Genitourinary diseases
19 Chronic renal failure 0.2 59.0 0.1 –6.5 0.3 0.0
20 Acute renal failure and insuﬃciency 0.1 74.5 0.1 –19.7 0.1 0.0
21 Genitourinary diseases –1.1 17.2 –0.2 –2.7 2.2 –0.1
Mental disorders
22 Depression 0.2 23.7 0.0 9.3 0.3 0.0
23 Other mental disorders –0.1 41.5 0.0 –4.6 1.4 –0.1
Nervous system and sense organs
24 Dementia and organic brain diseases 0.5 82.2 0.4 –4.7 1.1 0.0
25 Paralysis, Parkinson’s, etc. 0.1 70.0 0.1 –2.9 1.0 0.0
26 Glaucoma and cataract –0.7 25.0 –0.2 –11.3 1.4 –0.2
Blood
27 Anemia 0.7 37.4 0.3 –6.7 1.4 –0.1
28 Other blood diseases 0.0 11.5 0.0 2.9 0.4 0.0
(continued)greatly across diseases. People with musculoskeletal diagnoses receive joint
replacement and other surgeries, for example, and people with cardiovas-
cular disease receive various heart procedures. For some conditions—res-
piratory problems, mental illness, and nervous system disorders—no sur-
gical therapy is common.
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Table 5.3 (continued)
Eﬀect of change in:
Probability of condition Conditional disability rate
Condition dPr[C] Pr[DC] Total d(Pr[DC]) Pr[C] Total
Endocrine, nutritional, metabolic
29 Diabetes 1.7 31.3 0.5 –6.4 2.2 –0.1
30 Thyroid disorders 0.1 14.6 0.0 –9.7 0.3 0.0
31 Other metabolic and immunity disorders–0.1 30.8 0.0 –22.6 0.4 –0.1
Other
32 No condition –5.4 17.2 –0.9 –4.4 37.1 –1.6
33 Composite category 1.0 22.0 0.2 –8.8 7.3 –0.6
Total 1.8 –7.2
Note: See table 5.2 notes.
Table 5.4 List of common procedures
No./Procedure ICD-9-CM codes
3 Ops on spinal cord and spinal canal structures 03.∗ (~03.3)
13 Ops on lens 13.∗
14 Ops on retina, choroid, vitreous, and posterior chamber 14.∗ (~14.1)
34 Ops on chest wall, pleura, mediastinum, and diaphragm 34.∗ (~34.2)
35 Ops on valves and septa of heart 35.∗
36 Ops on vessels of heart 36.∗
37 Other ops on heart and pericardium 37.∗ (~37.2)
38 Incision, excision, and occlusion of vessels 38.∗ (~38.2)
39 Other ops on vessels 39.∗
45 Incision, excision, and anastomosis of intestine 45.0 (~45.1, 45.2)
51 Ops on gallbladder and biliary tract 51.∗ (~51.1)
53 Repair of hernia 53.∗
54 Other ops on abdominal region 54.∗ (~52.2)
57 Ops on urinary bladder 57.∗ (~57.3)
60 Ops on prostate and seminal vesicles 60.∗ (~60.1)
79 Reduction of fracture and dislocation 79.∗
80 Incision and excision of joint structures 80.∗
81 Repair and plastic ops on joint structures 81.∗
84 Other procedures on musculoskeletal system 84.∗
85 Ops on the breast 85.∗


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































yTable 5.6 shows the share of people with each condition that received
any of the indicated surgeries. There is a large increase in use of most pro-
cedures over time. Surgical increases are very common for patients with
musculoskeletal disorders; the percent of patients receiving surgery rose by
as much as 20 percent for many of these conditions. Surgery also increased
substantially for patients with circulatory disorders (especially heart dis-
ease) and diﬃculty seeing. Surgical increases were much smaller, or de-
clined, for patients with respiratory problems and cancer. The lower rate of
use of surgery for cancer patients is somewhat troubling, since almost all
such patients will receive some surgery. Most likely, the admissions for can-
cer here are palliative care patients, or patients who previously had surgery
and are now admitted for other therapies. These types of problems point
out the limitations of using claims data, but there is no alternative in this
case.
Estimating the impact of medical therapies on disability is diﬃcult. Con-
sider a cross-sectional regression relating disability to an indicator for
whether a person received an intensive procedure and a variety of other
factors (X):
(3) Pr(DCj)    0    1   Procedure Usej   Xj  εj.
The diﬃculty with estimating this equation is the nonrandom decision
about who receives which treatment. If the most severely ill patients receive
surgical care and are also likely to wind up disabled, the regression will
show that surgical procedure use is positively associated with disability,
when that is not the case. Some measures of sickness can be controlled for
in the X vector, but not all. Without an instrument for who receives diﬀer-
ent procedures that is independent of illness severity and general health
status, there is no easy solution to this problem.
To make progress, I use time series rather than cross-section variation.
The idea is the following: suppose that the underlying severity of disease
for each condition is the same over time. Then, conditions where procedure
use has expanded most should have the largest decline in disability. For-
mally, this can be expressed as
(4)  Pr(DCj)    0    1   Procedure Usej   εj,
where  Procedure Usej is the average change in procedure use for people
with each condition.
The identifying assumption here is that patient severity is the same over
time (hence, equation [4] can be estimated without X variables). The in-
crease in diagnosis of these conditions makes this somewhat problematic.
More patients diagnosed may raise or lower average severity of the group
with each condition. Future work could usefully address this by looking at
changes in comorbidities or other factors that illustrate disease severity.
Another concern is that other factors might inﬂuence disability. Imagine
Intensive Medical Technology and the Reduction in Disability 175Table 5.6 Use of surgery, by condition
1989 1999
Condition % of surgery N % of surgery N Change (%)
Musculoskeletal
1 Arthritis and arthropathy 12.1 407 29.4 588 17.3
2 Back/Neck pain 6.2 177 16.1 279 9.9
3 Hip and pelvic fracture 52.8 291 73.7 264 20.9
4 Musculoskeletal disorders 6.9 1,292 8.0 1,440 1.1
Digestive
5 Gastrointestinal disease 16.9 716 18.0 485 1.1
Respiratory
6 Chronic obstructive pulmonary diseases 
and related diseases — —
7R e spiratory failure and insuﬃciency — —
8R e spiratory diseases 3.9 524 1.2 579 –2.7
Circulatory
9 Stroke 9.5 579 12.0 805 2.5
10 Hypertension — —
11 Ischemic heart disease 13.4 269 27.3 205 13.9
12 Heart failure and arrhythmia 4.5 549 10.2 954 5.7
13 Peripheral vascular disease 23.7 198 27.5 232 3.8
14 Circulatory diseases 7.1 495 7.5 418 0.4
Infectious disease
15 Infectious diseases — —
Cancer
16 Colorectal and lung cancer 40.4 40 18.1 19 –22.3
17 Breast and prostate cancer 35.7 28 19.1 37 –16.6
18 Other cancers 5.7 166 22.2 98 16.5
Genitourinary diseases
19 Chronic renal failure 48.3 40 43.1 80 –5.2
20 Acute renal failure and insuﬃciency — —
21 Genitourinary diseases 22.3 315 13.4 172 –8.9
Mental disorders
22 Depression — —
23 Other mental disorders — —
Nervous system and sensory
24 Dementia and organic brain diseases — —
25 Paralysis, Parkinson’s, etc. — —
26 Glaucoma and cataract 55.2 207 73.3 122 18.1
Blood
27 Anemia — —
28 Other blood diseases — —
Endocrine, nutritional, metabolic
29 Diabetes 5.1 328 1.4 595 –3.7
30 Thyroid disorders — —
31 Other metabolic and immunity disorders — —
Other
32 No condition — —
33 Composite category — —
Notes: Surgeries are listed in table 5.5. Dashes indicate that no surgical procedures were identiﬁed.that a new pharmaceutical is developed that substitutes for surgery in some
cases. Surgery rates will fall, and concomitantly disability will decline. This
will bias the ﬁndings against showing an impact of medical technology on
health, although the opposite bias is possible as well. One task for the fu-
ture will be to consider which of these conditions have had important non-
surgical advances in treatments—pharmaceutical, environmental, or be-
havioral. For now, however, I do not address this.
Figure 5.2 shows the graphical relation between changes in intensive
procedure use and disability rates for people who have been diagnosed with
these conditions (the conditional disability rate). There is a clear negative
relation between the two. The coeﬃcient  1 in the regression above is esti-
mated to be –.27 (.13). The R2from the regression is not high (.13), but that
is not particularly surprising: there are many factors other than surgical
procedures that inﬂuence disability.
A comparison of the diﬀerent disease categories indicates what is being
picked up in the analysis. Intensive procedure use rose particularly rapidly
for people with musculoskeletal problems. The increase in use was as high
as 20 percent for some conditions. Those conditions also had very large de-
clines in disability, placing them in the bottom right quadrant of the ﬁgure.
Surgery rates for cancer fell or were relatively constant, however, and dis-
ability rates for cancer rose. Cancer diagnoses make up many of the condi-
tions toward the top left of the ﬁgure.
Overall, increased use of surgical procedures does not explain a large
part of the total reduction in disability. The constant term in the regres-
sion—the predicted change in disability with no change in surgery rates—
is about 7 percent. That is near the overall decline in conditional disability
rates shown in table 5.3. Further, the very strong declines in disability for
conditions where surgery is not an option show the importance of other
factors. Surgery seems to be important for some speciﬁc conditions, such
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Fig. 5.2 Change in probability of surgery and conditional disability
Source: Author’s calculations based on data from the National Long-Term Care Survey.as musculoskeletal disease and circulatory disorders, but is not a major
part of the decline for the vast bulk of patients.
5.4 Conclusions
This paper is a preliminary look at the factors leading to reduced dis-
ability among the elderly in the past two decades. Although the analysis is
still at the beginning stages, there are several important results. The data
show that lower disability is almost exclusively a result of reduced disabil-
ity for people who experience serious diseases rather than a result of fewer
people having serious diseases. The share of people who report having a se-
rious condition is actually rising over this time period, and the overall dis-
ability rate among the elderly would have increased were the health of the
disabled not improving. The substantial reduction in disability conditional
on disease incidence strongly suggests the possibility that medical care is a
factor in improved health.
Examining one important part of medical care—the use of intensive
surgical therapy—yields mixed results. Rates of surgery increased for
many disease categories. For conditions such as musculoskeletal problems
and circulatory disorders, higher rates of surgery are plausibly related to
reduced disability. But that is not true for all conditions. Many conditions
are not treated by surgical intervention, and yet disability for those con-
ditions fell as well. It is clear that other factors are also important in
explaining the better health of the elderly. Determining what those other
factors are is the subject of ongoing research. This paper presents a
framework to examine such eﬀects, and data that can shed light on the an-
swers.
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Comment Alan M. Garber
The Medicare Coverage Advisory Committee, appointed by the Health
Care Financing Administration (now HCFA) to help the Medicare pro-
gram make decisions about the coverage of speciﬁc medical procedures
and products, met in March of 2003 to consider a promising new technol-
ogy for the treatment of congestive heart failure. The technology, known
as a left ventricular assist device (LVAD), was originally approved as a
“bridge” to heart transplantation for patients with far advanced heart fail-
ure. Because the number of Americans with end-stage congestive heart
failure greatly exceeds the number who could receive heart transplants, in-
terest grew in the use of these devices as “destination therapy”—that is, as
the primary treatment for people who could not receive transplants.
The LVAD is a portable device that acts as an external pump to assist in
moving blood throughout the body, taking over part of the job of the irre-
versibly weakened heart of patients with very severe congestive heart fail-
ure. In a major clinical trial (REMATCH; Rose et al. 2001), patients who
were near death from congestive heart failure were randomly assigned to
treatment with LVAD placement or standard medical therapy. After twelve
months of treatment, nearly 80 percent of the medically treated patients
had died, while about half of the LVAD treated patients had died. Com-
plementing the greater survival rate of the LVAD patients was evidence of
improved quality of life. For example, the LVAD-treated group was less
likely to be depressed at the end of one year, and the severity of congestive
heart failure (New York Hospital Association score) was much lower in the
LVAD group. The trial established that the LVAD improved survival and
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gestive heart failure. Thus, this technological innovation improved survival
and, apparently, functional status. Because the prevalence of congestive
heart failure rises with age and the syndrome is very common among
Medicare beneﬁciaries, the LVAD has the potential to contribute to future
decreases in disability among the elderly.
Recent ﬁndings that the prevalence of disability has been declining
among older Americans have encouraged optimism about the health of fu-
ture cohorts of elderly Americans. The potential ramiﬁcations of declining
old age disability include longer working lives, diminishing needs for med-
ical and long-term care, and general improvements in the quality of life.
Particularly for aging baby boomers, these implications are momentous,
since they determine how this outsized cohort will spend an increasingly
large fraction of their lives. A better understanding of the causes of the dis-
ability decline might enable us to intervene to promote further declines in
disability, while helping us to know which aspects of progress would be in-
advertently threatened—or encouraged—by changes in health care ﬁ-
nancing and utilization. David Cutler’s paper takes an important step to-
ward addressing these issues by outlining an approach that relates changes
in disability to changes in the use of major medical procedures. His ap-
proach, if it is successful, will elucidate the roles of devices like LVADs and
other, less dramatic, procedures that may have contributed to the disabil-
ity decline.
The Disability Decline and Its Causes
Findings of declining disability rates among the elderly shifted the bal-
ance of a long-standing debate about disability trends. Many prominent re-
searchers hypothesized that medical advances were succeeding in keeping
people alive whose health conditions would have led to an earlier death in
years past (Verbrugge 1984). Though they could now survive longer with
their chronic conditions, they suﬀered greater impairments than previous
cohorts of survivors. This view of changes in health is based on the idea
that medical progress aﬀects survival more than functional status. The au-
tomated implantable deﬁbrillator, which prevents sudden cardiac death by
administering a shock to the heart when it goes into a deadly arrhythmia,
is a recently introduced technology that reduces death rates but does little
or nothing to alter the conditions that predispose patients to suﬀer sudden
cardiac death, such as coronary artery disease and congestive heart failure.
My Stanford colleague James Fries argued more than two decades ago
that trends pointed toward declining, not rising, old age disability (Fries
1980). Reductions in the incidence and severity of chronic diseases, he
claimed, would lead to reductions in the disability caused by those dis-
eases. Treatment of elevated blood pressure, for example, prevents death
from stroke by preventing the strokes themselves. Prevention of this com-
180 David M. Cutlermon complication of hypertension could result in declining age-adjusted
functional limitations attributable to stroke survivors.
Trends in disability seemed to vary with the speciﬁc disease or health
condition, and, until Kenneth Manton published his ﬁndings from the Na-
tional Long-Term Care Survey, it was unclear whether overall disability
among the elderly was increasing or decreasing. Manton showed that the
prevalence of disability was declining in successive cohorts of elderly
Medicare beneﬁciaries (Manton and Gu 2001). In the Manton study, as in
many others, disability is deﬁned by limitations in activities of daily living
(ADLs) or the less severe limitations in instrumental activities of daily liv-
ing (IADLs). The decline in the prevalence of IADL limitations was larger
in both absolute and relative terms than the decline in the prevalence of
ADL limitations.
These results, as David Cutler notes, have been conﬁrmed by other in-
vestigators and soon became the conventional wisdom. The results have
also changed the terms of debate in Washington, leading some legislators
to argue that fears about the coming insolvency of the Medicare program
are exaggerated.
There are at least two reasons to seek a better understanding of the
causes of the disability decline. The ﬁrst is that knowledge of the mecha-
nisms would increase our conﬁdence that the ﬁndings are valid and likely
to continue. That is, if we knew why the apparent decline in disability has
occurred, we would be in a better position to determine whether it is real
and likely to continue. Despite the shift in conventional wisdom, not all the
literature has conﬁrmed declining disability. Furthermore, the disability
decline reﬂects a disproportionate reduction in the prevalence of IADL im-
pairments, whose causes may be diﬀerent and impacts less signiﬁcant than
changes in the prevalence of limitations in basic ADLs. Instrumental ac-
tivities of daily living are measures of higher-order functioning, such as the
ability to balance a checkbook or shop without assistance. Simple tech-
nological aids, like availability of a calculator, might improve an IADL
without causing any improvement in underlying health. By learning more
about the mechanisms, we could obtain a more accurate impression of the
magnitude and signiﬁcance of the disability decline.
Second, a knowledge of mechanisms could point us toward interven-
tions that are likely to continue or even accelerate the disability decline. A
better understanding of the contributions of preventive care, medications,
surgical procedures, and other interventions would suggest where we
might see additional payoﬀs in the future. It is diﬃcult to exaggerate the
eﬀects of such ﬁndings on the well-being of the elderly.
Decomposing the Disability Decline
Cutler approaches the disability decline by decomposing it into changes
in the prevalence of disability-causing health conditions and changes in the
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composing mortality rate changes into components due to changes in dis-
ease incidence and changes in case fatality rates, or mortality conditional
on having the disease. This approach, if it can be applied successfully, will
make it clear whether it is the avoidance of disabling diseases or their more
eﬀective treatment that deserves more credit for the disability decline.
Implementing this seemingly simple decomposition is empirically chal-
lenging. Strictly speaking, the conditions should form an exhaustive and
mutually exclusive set, if they are to account for all of the changes in dis-
ability. Most people with severe disabilities have multiple chronic diseases,
and without further simplifying assumptions, each combination of condi-
tions (deﬁned also by varying severities) should make up a single compos-
ite condition. Even with a fairly limited set of single conditions, it is infea-
sible to incorporate the vast number of possible combinations that people
can have. Furthermore, Cutler reports that there is little clustering among
combinations of conditions, so it is not possible to account for a large frac-
tion of all combinations by limiting the analysis to a handful of the most
common ones. Cutler addresses these problems by assigning each individ-
ual to the single most severe (i.e., highest probability of being associated
with disability) of thirty-three conditions listed in his ﬁrst table. His results
show that, by and large, the incidence of health conditions rose with time,
while the probability of disability, given the health conditions, declined
with time. The decline in conditional disability was greater than the in-
crease in the incidence of the health condition.
The approximation required to ﬁt the conditions into a small number of
categories can have nontrivial consequences. For example, if the mix of dis-
ease conditions aggregated into one of the thirty-three categories changed
over time, it would falsely appear to be a change in conditional disability.
Furthermore, changes in either the prevalence of a condition or in its con-
ditional probability of disability may not be causal. For example, table 5.1
of Cutler’s paper shows that hypertension—an asymptomatic condition—
has a disability probability of 32 percent. Hypertension can eventually
cause disability by causing a stroke or heart attack, but these are separate
categories in the condition list, so it is hard to see why hypertension would
have an eﬀect on disability that is independent of these conditions. Genito-
urinary diseases, which by themselves are rarely disabling, by this method
appear to have a disability probability of 28 percent. It is very likely that
both of these conditions are associated with other health conditions that
are disabling. Preventing hypertension and genitourinary diseases, with-
out preventing associated conditions that cause the disabilities, would
surely result in a much smaller decrease in disability than predicted by this
framework.
Alternative approaches to the disability decomposition would give
diﬀerent, and possibly more accurate, results. One alternative would be to
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thirty-three) and to use a count of additional conditions to assign them to
an overall category.
Changes in diagnosis over time pose another problem for any attempt to
parse the eﬀects of changes in disease prevalence and changes in outcome
given disease. Improvements in screening tests, and increases in their
usage, are expected to introduce “lead-time bias.” Earlier diagnosis—a
longer lead time—means that survival conditional on disease will be
longer even if there is no eﬀective treatment. Improvements in diagnosis
are unlikely for some conditions that Cutler studies, such as hip fracture,
but for others—particularly some of the cancers—innovations in testing
may have increased both the prevalence of diagnosed disease and the frac-
tion of diagnosed disease that is in its early, and less symptomatic, stages.
The Relationship to Intensive Medical Care
As Cutler notes, “The important policy question is how much of the de-
cline in conditional disability rates is a result of medical intervention.” This
crucial question provides an ambitious focus for the research that he has
undertaken. He estimates the relationship between changes in conditional
disability and changes in intensive procedure use, noting that the results
may be confounded by a number of unmeasured characteristics. Among
them, and likely to be very important, are changes in the health of the pa-
tients who undergo a procedure; if procedure use diﬀuses from the very
sick to those who are less sick and at lower risk of disability, an increase in
use of the procedure may be spuriously associated with decreased disabil-
ity among those who receive it.
Despite the caveats that accompany any eﬀort of this kind, it represents
an important eﬀort to address a timely set of problems. If it is possible to
ﬁnd data and apply methods that are capable of establishing causal rela-
tionships, the work can provide a number of important insights. Cutler’s
model and others like it oﬀer basic building blocks toward projections of
medical care utilization and expenditures. More important, they can help
identify productivity opportunities at the margin, such as those that re-
sult from identifying a disease whose conditional disability has changed
little despite changes in prevalence over time. Finally, his results can also
shed light on the appropriateness of incentives embedded in the health
care system. Many disabling conditions might have eﬀective treatments
that are not covered: assistive devices, like hearing aids and visual aids,
often receive limited or no coverage under conventional health insurance
contracts. Not all opportunities to limit disability will arise from pre-
vention, pharmaceuticals, “medical” devices, or intensive procedures. A
reevaluation of the incentives embedded in our current approaches to
health care ﬁnancing might well lead to more appropriate care and better
outcomes.
Intensive Medical Technology and the Reduction in Disability 183References
Fries, J. F. 1980. Aging, natural death, and the compression of morbidity. New En-
gland Journal of Medicine 303:130–35.
Manton, K. G., and X. L. Gu. 2001. Changes in the prevalence of chronic disabil-
ity in the United States black and nonblack population above age 65 from 1982
to 1999. Proceedings of the National Academy of Sciences 98:6354–59.
Rose, E. A., A. C. Gelijns, A. J. Moskowitz, D. F. Heitjan, L. W. Stevenson,
W. Dembitsky, J. W. Long, D. D. Ascheim, A. R. Tierney, R. G. Levitan, et al.
for the Randomized Evaluation of Mechanical Assistance for the Treatment of
Congestive Heart Failure (REMATCH) study group. 2001. Long-term use of a
left ventricular assist device for end-stage heart failure. New England Journal of
Medicine 345:1435–43.
Verbrugge, L. 1984. Longer life but worsening health? Trends in health and mor-
tality of middle-aged and older persons. Milbank Memorial Fund Quarterly 62:
475– 519.
184 David M. Cutler